Pursuant to Regulation 29 read with Regulation 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that a Meeting of the Board of Directors of Medicamen Biotech Limited ( the Company ) is scheduled to be held on Friday, February 10, 2023 at the registered office of the Company situated at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019 to inter-alia, consider and approve the following business(s):1. The Un-audited Financial Results of the Company (Standalone and Consolidated) along with the Limited Review Report (Standalone & Consolidated) for the quarter and nine months ended on December 31, 2022. 2. Any other business with the permission of the chair.In this connection, please refer to our letter dated December 30, 2022, wherein it was informed that pursuant to the Company's Code of Conduct framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendments made there under, the trading window for dealing in the shares of the Company is closed for all designated persons of the Company from the January 01, 2023 and will open 48 hours after the said Financial Results are declared to the stock exchanges.This is for your information and record.